About Markus Wang

Markus Wang co-heads Bär & Karrer AG’s life science practice and focuses on IP, pharma-licensing and R&D, as well as drug and medical devices marketing/distribution. Markus’ practice covers patent or licensing-related litigation and arbitration in the pharmaceuticals, biotech, and medical device sectors, drafting, negotiating and advising clients in respect of complex licence, R&D, drug distribution and similar industry-specific agreements. Furthermore, he regularly deals with regulatory questions concerning advertising and distributing drugs, and represents clients vis-à-vis Swissmedic in related proceedings. Markus also serves on the boards of start-ups in the life sciences industry.